The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SWOG S1310: Randomized phase II trial of single agent MEK inhibitor trametinib vs. 5-fluorouracil or capecitabine in refractory advanced biliary cancer.
 
Richard D. Kim
Honoraria - Bayer; Genentech; Lilly; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Lilly; Taiho Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Eisai
 
Shannon L McDonough
No Relationships to Disclose
 
Anthony B. El-Khoueiry
Honoraria - Bayer; Bristol-Myers Squibb; Merrimack; Novartis
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CytomX Therapeutics
Speakers' Bureau - Merrimack
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Regeneron; Research to Practice; Taiho Pharmaceutical
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen
 
Stacey Stein
No Relationships to Disclose
 
Vaibhav Sahai
Honoraria - Celgene; Merrimack
Consulting or Advisory Role - Celgene
Research Funding - Celgene (Inst); Celgene (Inst)
 
George P. Keogh
Research Funding - BIND Therapeutics (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Gilead Sciences (Inst); Medivation (Inst); Merck (Inst); Pfizer (Inst)
 
Edward Jae-hoon Kim
Honoraria - Guardant Health; Pharmacyclics
Consulting or Advisory Role - Guardant Health; Pharmacyclics
Speakers' Bureau - Guardant Health
Research Funding - Celgene (Inst); Halozyme (Inst); OncoMed (Inst)
 
Ari David Baron
No Relationships to Disclose
 
Abby B. Siegel
Employment - Merck
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Merck
 
Afsaneh Barzi
Consulting or Advisory Role - bioTheranostics; Merrion
 
Katherine Guthrie
No Relationships to Disclose
 
Milind M. Javle
No Relationships to Disclose
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; Sirtex Medical